Yichang Hec Changjiang Pharmaceutical Co. Ltd. held its Annual General Meeting on May 29, 2025. During the meeting, several proposals were reviewed and approved. These included the re-appointment of KPMG as auditor for a term until the next annual general meeting, the report of the Board of Directors for the year ended December 31, 2024, and the report of the Supervisory Committee for the same period. Additionally, the audited consolidated financial statements for the year ended December 31, 2024, were approved, as well as the profit distribution plan for the year. All proposals were passed as ordinary resolutions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。